Prof. Sian M. Henson currently serves as a Professor of Immunology at the Center of Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. She obtained her PhD at Imperial College London in 2000. Subsequently, she undertook postdoctoral training with Prof Richard Aspinall at Imperial College, investigating the role of IL-7 in thymic atrophy. She then moved to Prof Arne Akbar’s lab at University College London where she directed her focus toward understanding the role of inhibitory receptors during aging and found that senescence is not a passive end-stage process but is controlled by active signaling pathways. More recently, she has become interested in the metabolic requirements of primary human senescent T cells. She became a lecturer at the William Harvey Research Institute in 2015 where she established her own research group investigating the deregulation of T cell metabolism during human aging and how it maintains an inflammatory deleterious state. Prof. Henson serves as a committee member for the BBSRC and the Dunhill Medical Trust. She is the Chair of the British Society of Immunology affinity group for Immune Senescence. She is also an Associate Editor for Frontiers of Immunology. Her current academic roles include being module lead for Immunology for the Biomedical Sciences BSc.
Dr. Jordi L. Tremoleda is a Designated Veterinarian and a Reader in Animal Science and Welfare at the Queen Mary University of London. He completed his Master's studies in Bioethics and Law at Universitat de Barcelona and PhD studies in Philosophy at Universiteit Utrecht. His research brings together complex models of trauma, hemorrhage, shock, coagulopathy, and central nervous injury to facilitate the full translation of experimental work into clinical practice.
Prof. Adina T. Michael-Titus is currently Professor of Neuroscience and Centre Lead for the Centre for Neuroscience, Surgery and Trauma, at the Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. Professor Michael-Titus is a Fellow of the British Pharmacological Society and, in the last two decades, her research has been focused on neuroprotection and neurorepair strategies in traumatic spinal cord injury and brain injury. Her main interest is in the development of new therapeutic interventions for improved management of spinal cord injury and brain injury patients. Her current projects include the exploration of fatty acids for acute neuroprotection, combinatorial strategies for enhanced recovery after neurotrauma, and the link between traumatic brain injury and brain senescence. Professor Michael-Titus is the President of the International
Society for the Study of Fatty Acids and Lipids.
